Next Article in Journal
5-aza-2′,2′-Difluoro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer
Next Article in Special Issue
Endolysosomal Cation Channels and Cancer—A Link with Great Potential
Previous Article in Journal
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP
Previous Article in Special Issue
Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target
Open AccessEditorial

Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts

AbbVie Inc, 1 North Waukegan Road, North Chicago, IL 60064, USA
Baptist Medical Center, 800 Prudential Drive, Jacksonville, FL 32207, USA
Author to whom correspondence should be addressed.
Pharmaceuticals 2017, 10(3), 64;
Received: 25 June 2017 / Revised: 26 June 2017 / Accepted: 26 June 2017 / Published: 6 July 2017
2017 marks the 20th anniversary of the molecular cloning by David Julius and colleagues (1997) of the long sought-after capsaicin receptor, now known as TRPV1 (Transient Receptor Potential Vanilloid 1) [1]. This seminal discovery has opened up a “hot” new field of basic research and launched drug discovery efforts into the large family (by the latest count 28 mammalian members, 27 in humans) of TRP ion channels [2]. Indeed, it took less than a decade for the first potent, small molecule TRPV1 antagonists to enter phase 1 clinical trials [3]. Yet, despite the large amount of resources that has been invested in TRPV1 research, there are currently no TRPV1-targeted drugs in phase 3 clinical trials. In this special issue of Pharmaceuticals, we aim to capture the progress in the TRP channel field over the past twenty years, with 15 articles covering a variety of TRP channels and potential relevant disease states and applications. View Full-Text
Keywords: Transient Receptor Potential Channels; TRP; Drug Discovery Transient Receptor Potential Channels; TRP; Drug Discovery
MDPI and ACS Style

Huang, S.; Szallasi, A. Transient Receptor Potential (TRP) Channels in Drug Discovery: Old Concepts & New Thoughts. Pharmaceuticals 2017, 10, 64.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop